Stay updated on Risankizumab in Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab in Psoriatic Arthritis Clinical Trial page.

Latest updates to the Risankizumab in Psoriatic Arthritis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check7 days agoChange DetectedThe page now presents the complete study record with links to key PDFs and IPD sharing information, replacing the prior error and making the KEEPsAKE 2 details accessible.SummaryDifference100%

- Check14 days agoChange DetectedThe page now displays a 403 Forbidden error page instead of the study record content, effectively blocking access to the NCT03671148 study details on ClinicalTrials.gov.SummaryDifference19%

- Check36 days agoChange DetectedAdded '2023 ( U.S. NIH Grant/Contract )' to the study identifiers. Updated the page revision from v3.6.5 to v3.6.6.SummaryDifference0.0%

- Check57 days agoChange DetectedThe revision label changed from v3.6.4 to v3.6.5 on the page, indicating a small update to the page’s version. It does not alter the study details or user-facing functionality.SummaryDifference0.0%

- Check72 days agoChange DetectedThe study record status changed from Active, not recruiting to Completed, indicating that participant enrollment has ended. This update also notes a new last update date (2026-07-20) and a revision bump to v3.6.4.SummaryDifference0.2%

- Check93 days agoChange DetectedRevision: v3.6.3 is now displayed, replacing Revision: v3.6.2. This appears to be a versioning/template update rather than a change to page content or user-facing information.SummaryDifference0.0%

Stay in the know with updates to Risankizumab in Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab in Psoriatic Arthritis Clinical Trial page.